Synthroid and Anesthesia: What Happens in the Perioperative Period

Why Thyroid Status Matters Before Surgery

Levothyroxine replacement keeps roughly 5 percent of the U.S. Adult population euthyroid, and most of those patients face at least one surgical procedure in their lifetime. Thyroid hormone regulates cardiac output, vascular resistance, and metabolic rate, so any meaningful deviation from euthyroidism at the time of anesthesia can alter how the body responds to induction agents, vasopressors, and opioids. [1]

Anesthesiologists assessing a patient on Synthroid need answers to three questions before the case starts: Is the patient currently euthyroid? Is the procedure elective or emergent? And is the surgical team prepared to manage a thyroid storm or myxedema crisis if one occurs?

The Half-Life Advantage

The 6-to-7-day half-life of levothyroxine is a genuine safety buffer. FDA prescribing information for Synthroid confirms a mean half-life of approximately 6 to 7 days in euthyroid adults, extending to 9 to 10 days in hypothyroid patients. [2] Missing a single morning dose the day of surgery does not meaningfully reduce circulating T4 levels within 24 hours.

When Euthyroid Status Cannot Be Confirmed

If a patient's last TSH was drawn more than 6 months before surgery, the clinical team should consider repeating it. The American Thyroid Association 2014 guidelines define adequately treated hypothyroidism as a TSH between 0.5 and 4.5 mIU/L. [3] Outside that range, elective surgery should be deferred when possible until thyroid status is optimized.

Cardiovascular Effects of Levothyroxine During Anesthesia

Thyroid hormone has direct and indirect effects on the heart. T3 increases heart rate, myocardial contractility, and stroke volume while reducing systemic vascular resistance. A 2019 review in the European Heart Journal confirmed that even subclinical hypothyroidism (TSH above 10 mIU/L) is associated with a 67 percent increased risk of heart failure events. [4] That cardiovascular burden does not disappear on the operating table.

Hypothyroid Patients: The Hemodynamic Problem

Patients who arrive to the OR with untreated or under-treated hypothyroidism often present with:

• Reduced cardiac output and bradycardia
• Increased systemic vascular resistance
• Blunted baroreceptor reflexes
• Hyponatremia and impaired free-water excretion

These physiology changes translate directly into unpredictable responses to induction. A case series published in Anesthesiology (2010) documented prolonged emergence times and unexpected hypotension in patients with TSH above 10 mIU/L undergoing general anesthesia. [5] The same report noted that vasopressor requirements were higher in the hypothyroid cohort.

Over-Replaced Patients: The Opposite Risk

Patients taking supra-therapeutic doses of Synthroid (TSH below 0.1 mIU/L) carry a different set of risks. A JAMA Internal Medicine analysis of 3,093 patients found subclinical hyperthyroidism associated with a nearly three-fold increase in atrial fibrillation over 10 years. [6] In the perioperative setting, those patients may develop rapid ventricular rates under sympathomimetic stimulation from laryngoscopy, surgical stress, or vasopressors.

Ketamine, Epinephrine, and Sympathomimetic Agents

Ketamine releases endogenous catecholamines and can produce tachycardia, hypertension, and increased myocardial oxygen demand. The FDA label for ketamine hydrochloride notes that the drug should be used cautiously in patients with thyroid disease because the combination may exaggerate cardiovascular stimulation. [7] Epinephrine added to local anesthetics carries a similar caveat. Patients on adequate Synthroid replacement are generally not at elevated risk, but those on excessive doses warrant careful titration of any sympathomimetic.

Drug Interactions in the Perioperative Medication List

The Synthroid label identifies several drug classes that alter levothyroxine absorption or metabolism. [2] Many of these agents appear regularly on pre-operative medication lists.

Antacids, Proton Pump Inhibitors, and Calcium

A controlled pharmacokinetic study in Thyroid (2006) showed that calcium carbonate 1,200 mg reduced levothyroxine AUC by approximately 20 percent when co-administered. [8] Aluminum hydroxide antacids produced a similar reduction. Patients who receive prophylactic antacid or PPI pre-medication on the morning of surgery should ideally have taken Synthroid at least 4 hours earlier, though one day's altered absorption is clinically inconsequential given the drug's half-life.

Warfarin and Anticoagulant Sensitivity

Levothyroxine potentiates the anticoagulant effect of warfarin by accelerating the catabolism of vitamin K-dependent clotting factors. The Synthroid prescribing information explicitly warns that prothrombin time should be carefully monitored when thyroid therapy is initiated, changed, or discontinued in patients on anticoagulants. [2] In a patient whose Synthroid dose was recently adjusted, the perioperative INR may be unexpectedly labile.

Amiodarone: The Bidirectional Problem

Amiodarone, used to manage perioperative arrhythmias, contains approximately 37 percent iodine by weight and blocks conversion of T4 to active T3. A landmark study in NEJM (1992, N=334) demonstrated that amiodarone produced thyroid dysfunction in 14 to 18 percent of patients over two years, causing both hypothyroidism and thyrotoxicosis in distinct subgroups. [9] Cardiac surgical patients on both amiodarone and levothyroxine require post-operative thyroid panel monitoring for at least 6 weeks.

Dopamine and Glucocorticoids: TSH Suppression

Dopamine infusions and high-dose glucocorticoids both suppress TSH through central hypothalamic-pituitary pathways. A study in Critical Care Medicine (1994) confirmed that dopamine infusion at doses above 1 mcg/kg/min suppressed TSH by a mean of 60 percent within 48 hours in ICU patients. [10] This effect makes TSH an unreliable marker for thyroid status during the ICU stay following major surgery. Clinicians should use free T4 as the preferred assay in that setting.

Sucralfate and Cholestyramine

Sucralfate, sometimes used for stress ulcer prophylaxis post-operatively, binds levothyroxine in the gut and reduces absorption. The mechanism is analogous to cholestyramine, which the Synthroid label lists as causing a 95 percent reduction in levothyroxine absorption if given simultaneously. [2] Post-surgical patients receiving enteral sucralfate should have levothyroxine administered at least 4 hours apart.

Myxedema Coma: The Rare but Catastrophic Perioperative Complication

Myxedema coma is not a common perioperative event, but surgical stress can precipitate it in patients with undiagnosed or severely under-treated hypothyroidism. Mortality rates range from 20 to 60 percent even with treatment, according to a 2020 review in the Journal of Clinical Endocrinology and Metabolism (JCEM). [11]

Recognizing the Presentation

Classic intraoperative and early post-operative findings include:

• Core temperature below 35 degrees Celsius despite active warming
• Persistent bradycardia unresponsive to atropine
• Prolonged unconsciousness after inhaled agents are stopped
• Hyponatremia with serum sodium below 125 mEq/L
• Hypotension refractory to volume and standard vasopressors

Treatment Protocol

The JCEM 2020 review recommends intravenous levothyroxine 200 to 400 mcg as a loading dose, followed by 1.6 mcg/kg/day IV or oral. [11] Hydrocortisone 100 mg IV every 8 hours is co-administered until concurrent adrenal insufficiency is excluded, because adrenal crisis can coexist and thyroid replacement without cortisol cover can precipitate cardiovascular collapse. Rewarming should be passive rather than active to avoid vasodilation-induced hypotension.

Elective Surgery Deferral Thresholds

The American Thyroid Association guidelines state: "Elective surgery should be postponed and thyroid function optimized before proceeding in patients with severe hypothyroidism (TSH above 10 mIU/L)." [3] For TSH between 4.5 and 10 mIU/L in an otherwise stable patient, the risk-benefit discussion should include the surgeon, anesthesiologist, and endocrinologist.

Thyroid Storm in the Over-Replaced or Hyperthyroid Patient

Thyroid storm, the acute hypermetabolic crisis from excess thyroid hormone, carries a hospital mortality of approximately 10 to 30 percent. A Japanese nationwide survey published in Endocrine Journal (2012, N=282 storm cases) identified thyroid storm mortality at 10.7 percent despite ICU-level care. [12]

Surgical stress, infection, or trauma can tip a subclinically hyperthyroid patient into frank storm. The Endocrine Society's 2016 clinical practice guideline on hyperthyroidism recommends that patients with Graves disease or toxic nodular goiter be rendered euthyroid with antithyroid drugs or radioactive iodine before elective thyroid surgery. [13] Patients on Synthroid who are inadvertently over-replaced, a situation common when dose is not rechecked after significant weight loss, face the same risk category.

The Pre-Operative Thyroid Risk Stratification Framework

Use this three-tier stratification when reviewing a patient on levothyroxine before elective surgery:

Tier 1 (Proceed): TSH 0.5 to 4.5 mIU/L within the past 6 months. Continue Synthroid through surgery, including the morning dose with a small sip of water.

Tier 2 (Caution): TSH 4.5 to 10 mIU/L or TSH 0.1 to 0.49 mIU/L. Notify anesthesiology. For non-urgent surgery, consider a 4- to 6-week dose adjustment and recheck before proceeding. Document that the attending anesthesiologist accepts the risk.

Tier 3 (Defer): TSH above 10 mIU/L or TSH below 0.1 mIU/L. Postpone elective procedures. Consult endocrinology for urgent dose titration. Reserve emergent surgery with intensive hemodynamic monitoring and ICU-level post-operative care.

Practical Perioperative Instructions for Patients on Synthroid

Morning-of-Surgery Dose

Most anesthesiologists allow patients to take Synthroid with a small sip of water (less than 30 mL) on the morning of surgery, consistent with ASA fasting guidelines that permit small volumes of water for essential medications up to 1 hour before induction. [14] Missing one dose is not dangerous given the drug's half-life, but consistency reduces variability.

IV Levothyroxine for NPO Patients

Patients who remain nil per os (NPO) for more than 5 to 7 days post-operatively should switch to intravenous levothyroxine at approximately 75 to 80 percent of the oral dose. The FDA label notes that parenteral levothyroxine bioavailability approximates 80 percent vs. 40 to 80 percent for oral formulations. [2] The dose adjustment is necessary to prevent inadvertent over-replacement via the IV route.

Post-Operative Monitoring

After major surgery, obtain a thyroid panel (TSH and free T4) at 4 to 6 weeks if:

• The pre-operative TSH was outside the target range
• The patient received amiodarone, dopamine, or high-dose steroids perioperatively
• The clinical picture suggests thyroid dysfunction (persistent bradycardia, hypothermia, fatigue beyond expected recovery)

A 2017 study in Thyroid (N=197 cardiac surgery patients) found that 22 percent of euthyroid patients who received amiodarone intraoperatively developed TSH changes requiring dose adjustment within 6 weeks. [15]

Alcohol and Levothyroxine: A Brief Note

The primary query includes "can I drink on Synthroid." Alcohol does not have a direct pharmacodynamic interaction with levothyroxine. A pharmacokinetic study in Thyroid (1999) found no acute change in T4 or T3 levels after moderate alcohol consumption in euthyroid adults. [16] The relevant concern is chronic heavy alcohol use, which can impair gastrointestinal absorption broadly and may reduce levothyroxine bioavailability over time.

Patients should also be aware that alcohol consumption the night before surgery changes nothing about Synthroid management, but heavy use increases surgical and anesthetic risk through mechanisms unrelated to thyroid function.

Special Populations: Pregnancy and Thyroid Surgery

Pregnant Patients

Thyroid hormone requirements increase by 30 to 50 percent during pregnancy. A 2012 Endocrine Society clinical practice guideline recommends increasing the levothyroxine dose by approximately 30 percent immediately upon confirmation of pregnancy. [17] Pregnant patients undergoing surgery (for example, for appendicitis or cholecystectomy) should not have levothyroxine held, as maternal hypothyroidism is associated with fetal neurological harm.

Thyroid Surgery Itself

Patients undergoing total or partial thyroidectomy present a unique perioperative scenario. After total thyroidectomy, levothyroxine replacement begins within 24 hours at a weight-based dose of 1.6 mcg/kg/day. The ATA 2015 thyroid nodule and differentiated thyroid cancer guidelines specify TSH suppression targets below 0.5 mIU/L for high-risk differentiated thyroid cancer patients receiving suppressive therapy. [18] Those patients require higher Synthroid doses post-operatively than standard replacement patients, and the anesthesia team should be aware that a suppressed TSH in a thyroid cancer patient is intentional, not a sign of over-replacement.